Skip to content
Screener

Total Revenue at other companies

Eli Lilly logo
Eli LillyLLY
$22.97B+47.7%
Pfizer logo
PfizerPFE
$15.03B+2.6%
Merck & Co. logo
Merck & Co.MRK
$16.61B+5.1%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$3.33B+12.5%
Cytokinetics logo
CytokineticsCYTK
$28.62M-57.1%
Mannkind logo
MannkindMNKD
$109.37M+42.9%

Segments

By segment

See full
Reportable Segment$692K-97.6%

By product

See full
License$0-100%

Other financials

Income statement

See full
Gross profit$653.0K-97.7%
Operating income-$26.5M-810%
Net income-$31.8M-1,077%
EPS (diluted)-$0.07-800%

Balance sheet

See full
Cash & equivalents$40.9M-18.7%
Total debt$59.2M-3.6%
Total equity$174.5M+34.8%
Total assets$250.1M+10.9%

Cash flow

See full
Operating cash flow-$9.2M
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$1.05B+151%
Enterprise value$1.07B+149%
P/S25.3×+18.1×

Profitability

See full
Gross margin99.1%0.0pp
Operating margin-131.4%-34.2pp
Net margin-147.4%-32.8pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-40.2%-11.2pp
Debt / equity0.3×-0.1×
Current ratio13.4×+9.2×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001062822-26-000117
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net product revenue$680$1,322$1,770$2,584
Licensing and milestone revenue27,54420,00027,544
Royalties and other revenue1224
Total revenues69228,86621,79430,128
Operating expenses:
Cost of sales393314763
Research and development, including stock-based compensation of $1,384, $1,620, $2,753, and $3,194 respectively17,44315,74730,19931,050
Selling, general and administrative, including stock-based compensation of $1,952, $1,575, $3,661, and $3,044 respectively9,7509,35018,98420,958

Item 1. Financial Statements

FAQ

What is Lexicon Pharmaceuticals's total revenue?
Lexicon Pharmaceuticals (LXRX) reported total revenue of $692K in Q2 2026.
How has Lexicon Pharmaceuticals's total revenue changed year-over-year?
Lexicon Pharmaceuticals's total revenue decreased by 97.6% year-over-year, from $28.87M to $692K.
What is the long-term trend for Lexicon Pharmaceuticals's total revenue?
Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's total revenue has grown at a 259.6% compound annual growth rate (CAGR), from $298K to $49.8M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Lexicon Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude